Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Gross Profit | 2,000 | 2,030 | -470 | -210 | -820 |
| Operating Expenses | 5,160 | 4,910 | 5,220 | 4,510 | 4,040 |
| Operating Income | -5,160 | -4,910 | -5,220 | -4,510 | -4,040 |
| Pre-tax Income | -5,160 | -4,910 | -5,220 | -4,510 | -4,040 |
| Net Income Continuous | -5,160 | -4,910 | -5,220 | -4,510 | -4,040 |
| Net Income | $-5,160 | $-4,910 | $-5,220 | $-4,510 | $-4,040 |
| EBITDA(a) | $-3,740 | $-3,430 | $-3,520 | $-3,630 | $-3,100 |